Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuko Sakai

Showing results (1-10 of 238) with videos related to

Pageof 24
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Current Status and Future Direction of Cancer Genomic Medicine]Kazuto Nishio, Kazuko Sakai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Application of NGS-Based Clinical Sequencing]Kazuto Nishio, Kazuko Sakai
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[PI3K and mTOR pathway and molecular targeted agents]Kazuto Nishio, Kazuko Sakai, Yosuke Togashi
Genetics|July 23, 2003
The mitotic DNA damage checkpoint proteins Rad17 and Rad24 are required for repair of double-strand breaks during meiosis in yeastMiki Shinohara, Kazuko Sakai, Tomoko Ogawa, et al.
Pigment Cell & Melanoma Research|December 9, 2016
Phylloid hypomelanosis associated with a mosaic trisomy 13 in the 13q31.3-qter region: atypical phylloid distribution and typical hypomelanosisNaoki Oiso, Kazuko Sakai, Kazuto Nishio, et al.
Oncotargets and Therapy|July 31, 2019
Successful long-term treatment of non-small cell lung cancer positive for <i>RET</i> rearrangement with pemetrexedMasayuki Takeda, Kazuko Sakai, Kazuto Nishio, et al.
Genetics|April 19, 2003
Crossover interference in Saccharomyces cerevisiae requires a TID1/RDH54- and DMC1-dependent pathwayMiki Shinohara, Kazuko Sakai, Akira Shinohara, et al.
Oncology Letters|December 2, 2014
Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoterKazuko Sakai, Masayuki Takeda, Isamu Okamoto, et al.
Molecular and Clinical Oncology|July 28, 2020
Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expressionHitomi Sakai, Masayuki Takeda, Kazuko Sakai, et al.
European Journal of Dermatology : EJD|April 7, 2018
Genital mucosal melanoma with somatic SF3B1 R625C mutationNaoki Oiso, Kazuko Sakai, Shigeto Yanagihara, et al.
Pageof 24

Showing results (1-10 of 238) with videos related to

Sort By:
Pageof 24
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 19, 2019
[Current Status and Future Direction of Cancer Genomic Medicine]Kazuto Nishio, Kazuko Sakai
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Application of NGS-Based Clinical Sequencing]Kazuto Nishio, Kazuko Sakai
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[PI3K and mTOR pathway and molecular targeted agents]Kazuto Nishio, Kazuko Sakai, Yosuke Togashi
Genetics|July 23, 2003
The mitotic DNA damage checkpoint proteins Rad17 and Rad24 are required for repair of double-strand breaks during meiosis in yeastMiki Shinohara, Kazuko Sakai, Tomoko Ogawa, et al.
Pigment Cell & Melanoma Research|December 9, 2016
Phylloid hypomelanosis associated with a mosaic trisomy 13 in the 13q31.3-qter region: atypical phylloid distribution and typical hypomelanosisNaoki Oiso, Kazuko Sakai, Kazuto Nishio, et al.
Oncotargets and Therapy|July 31, 2019
Successful long-term treatment of non-small cell lung cancer positive for <i>RET</i> rearrangement with pemetrexedMasayuki Takeda, Kazuko Sakai, Kazuto Nishio, et al.
Genetics|April 19, 2003
Crossover interference in Saccharomyces cerevisiae requires a TID1/RDH54- and DMC1-dependent pathwayMiki Shinohara, Kazuko Sakai, Akira Shinohara, et al.
Oncology Letters|December 2, 2014
Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoterKazuko Sakai, Masayuki Takeda, Isamu Okamoto, et al.
Molecular and Clinical Oncology|July 28, 2020
Long-term response to ipilimumab after nivolumab failure in a case of anorectal melanoma with an intermediate tumor mutation burden and negative for PD-L1 expressionHitomi Sakai, Masayuki Takeda, Kazuko Sakai, et al.
European Journal of Dermatology : EJD|April 7, 2018
Genital mucosal melanoma with somatic SF3B1 R625C mutationNaoki Oiso, Kazuko Sakai, Shigeto Yanagihara, et al.
Pageof 24